Eastern Health MS Service. Tysabri Therapy. Information for People with MS and their Families

Size: px
Start display at page:

Download "Eastern Health MS Service. Tysabri Therapy. Information for People with MS and their Families"

Transcription

1 Eastern Health MS Service Tysabri Therapy Information for People with MS and their Families The Eastern Health MS Service has developed this information for you as a guide through what will happen to you on Tysabri (also called Natalizumab) therapy. By now, you and your Neurologist have already talked about Tysabri as an MS treatment option for you. This resource is an addition to your ongoing discussions with your Neurologist and MS Nurse. We want to assure you that the MS team is always available to answer any further questions you may have. Before Starting Tysabri Therapy 1. How Tysabri works, how it will affect you and what to expect from the therapy What is Tysabri and how does it work for people with MS? In MS, inflammation occurs in the brain and damages the nerve cells and the protective covering of the nerve cells (the myelin). Inflammatory cells, called white blood cells, cross over into the brain and produce abnormal patches of inflammation that result in MS lesions. Tysabri is a protein that binds like a lock and key to these white bloods cells, preventing the cells crossing from the blood stream into the brain and causing inflammation and damage. What are the side effects of Tysabri and how will it make me feel? Tysabri has some unwanted side effects in a small percentage of people. It is very important that you understand and have had an opportunity to discuss possible side effects of Tysabri. Common side effects The most common side effect which occurs in about 25% of people on Tysabri is an infusion reaction. These reactions usually mild and resolve quickly with or without medications. Such reactions may include headache, nausea, fatigue or dizziness and joint pain. If you experience any of these symptoms, please advise the nurse administering Tysabri.

2 Rare side effects In less than 1% of patients, a more serious hypersensitivity or allergic reaction can occur. Symptoms of this type of reaction may include: - an itchy rash, hives - swelling of your face, lips, tongue or other parts of the body - shortness of breath, wheezing, difficulty breathing or chest pain. You need to speak to your nurse immediately if you notice any of these symptoms during or after your infusion. These reactions are treatable with medications, but require immediate medical attention and an additional observation period (4 hours). Very rare side effects Progressive Multifocal Leukoencephalopathy (PML) The risk of this illness is very low (1 in 4000) however this is a very serious problem that can result in death or serious disability. The cause of PML is a virus attacking the brain. There are no tests that can screen for PML before you start therapy, however early diagnosis is important in improving long term outcomes. It is very important you inform your MS nurse or doctor of any new symptoms that are persisting beyond two days (for example confusion or impaired thinking, or changes in strength, balance or vision). The use of other immunosuppressive and cancer drugs in combination with Tysabri may increase the risk of PML. You should never take other immunosuppressive medication, interferon or Copaxone at the same time as Tysabri. Other Opportunistic Infections Other Opportunistic Infections (such as herpes and chest infections) have been rarely reported with Tysabri. Liver Function Test abnormalities Rare cases of reversible liver damage(less than 1 in 1000) have been reported. A blood test will be performed to check your liver function after the first dose, second dose and fifth dose. 2. Investigations and assessment before you start your first dose Before you start Tysabri therapy you will need to have a number of tests to help in the early detection and prevention of any possible side effects. Your neurologist and MS Nurse can help explain these tests and can give you the test results as soon as they are available. The tests include: Blood tests These tests assist in establishing some of your normal bodily patterns. We are then able to detect any changes should they occur and help us monitor your liver function, immune system and overall immune functioning. These tests are called Full Blood Examination (FBE) and Liver Function Test (LFT).

3 Further blood tests which are required before starting Tysabri relate to the rare risk of Tysabri therapy making you more susceptible to a worsening of certain types of viruses and infections if you already have them in your body. These tests include checking for chicken pox virus (Varicella), Hepatitis B and C viruses and Human Immunodeficiency virus (HIV). Currently, no blood test is available to screen for PML. MRI brain scan An MRI of your brain is necessary within 3 months of starting Tysabri. This MRI is used as a comparison to later MRIs to detect any changes during therapy. Once all of these tests have been completed and the Neurologist has looked at the results and talked them over with you, you are ready to start therapy. The MS team will write a letter to your local doctor and any other health professionals you nominate to let them know that you will be starting the therapy. 3. Considerations before starting Tysabri Therapy Tysabri is a monthly therapy Tysabri therapy requires a day admission to hospital every 28 days (4 weeks). If there is interruption to this routine treatment, there is a risk of a serious reaction developing that may mean you have to stop treatment altogether. If exceptional circumstances prevent you from attending your appointment, there is a small window (plus or minus one week in which you can receive the treatment. It is strongly recommended that you take time to consider the impact that this regime will have on your lifestyle before you decide to start Tysabri. To help you consider its impact you are asked to consider these questions: - Are you planning a long overseas holiday? - What impact will this treatment pattern have on your work commitments? - Does your work require you to travel frequently? - What other time commitments (such as non-work meetings or events) will interfere with your treatment regime? - Are you planning to have a family or extend your family? Taking the time to discuss these issues with your family, friends and health care team will mean that you are prepared and able to make the commitment required for this continuous therapy. Fertility, pregnancy and contraception Tysabri is not recommended during pregnancy or breastfeeding and should be discontinued three months before planning to become pregnant. If you suspect that you are, or may be, pregnant during this therapy you must notify your health care team before you have any further doses of Tysabri.

4 If you are planning to extend your family you will need to discuss this issue your Neurologist. Studies in male fertility in animals found no genetic changes in male sperm. In female animals, high doses of Tysabri caused increased risk of miscarriage. It is recommended that all men and women receiving Tysabri should practice medically effective contraception, such as the contraceptive pill or a combination of barrier methods. Beginning Tysabri Therapy 1. The Tysabri Therapy Service at Eastern Health The Eastern Health MS Service strives to provide you with a Tysabri service that provides optimal care and fits in with your lifestyle. As part of this goal, the MS Nurse is available at any stage of your Tysabri therapy journey to listen, answer your questions, and endeavour to meet your needs. When can I receive my treatment? The Tysabri Infusion Service is currently provided on Saturday and occasional Thursday afternoon sessions. The MS Nurse will discuss with you the timing of your session before you start therapy. Where is the Tysabri Infusion given? The Tysabri infusion is given in a Day Infusion Centre (also called Day Oncology Unit) on the 3 rd Floor of the main building of Box Hill Hospital. To get to the Infusion Centre take the lift with the red dot and exit at the third floor. Getting to and from the Infusion Centre There is no medical reason why you can t drive yourself to and from the Infusion Centre. However, you may feel more comfortable having a family member or friend drive you, especially for the first infusion. Please ask the MS Nurse about parking arrangements and she will explain the options. All-day parking is available along Nelson road opposite the hospital. How long does it take to give the Infusion? The Infusion Centre is set up with comfortable recliner chairs. When you arrive you will be admitted and your paperwork completed and then you can find yourself a comfortable chair. You will be required to complete a short Tysabri questionnaire. The nurses will then prepare and start the infusion. The infusion itself takes 2 hours. The total time required for an Infusion session is usually about 3 hours. Who administers the Infusion? The nursing staff who care for you during the Infusion sessions have received specialist training in the administration of Tysabri. We aim to ensure that you have the same nurses at your sessions so that you get to know each other and so, over time, the nurses come to understand your individual needs.

5 The MS Nurse will be available at the time of Infusion to support you and to answer any questions you may have. A medical Neurology team and Neurologist will be on call to help if needed. Respecting and caring for others Other people will be at the Infusion Centre receiving Tysabri and other specialised infusions during the day. While you may wish to speak to the people around you we do ask that you speak quietly and ensure that you ask the person s permission before you approach them. We must respect people s desire and need for privacy. Television sets are available. You may like to bring something to read or listen to. You can bring a family member or friend to keep you company. However, for your own and other s comfort and safety, we ask that you bring only one other person and arrange care for children at home. If you are not able to arrange care at home for your children, please speak to the MS Nurse to examine possible alternatives. If I can t attend can I miss a dose? Tysabri is a therapy that needs to be given every 4 weeks. It has been demonstrated that if you miss a dose you have an increased risk of a serious infusion reaction occurs that means you can no longer receive therapy. Only under exceptional circumstances could the possibility of an alternate infusion date be considered, this must be discussed with the MS team well in advance.

6 Your First Infusion of Tysabri The first step is often the most challenging as many people who start Tysabri feel apprehensive about the first dose. The MS Nurse will be available to provide you with reassurance and answer any questions you have. The Tysabri Infusion Journey Complete the pre-infusion questionnaire and go through it with the nurse, discussing any changes in your health and well-being, any new medications or any concerns. Your blood pressure, heart rate and temperature will be checked and any other necessary assessments done. Tysabri is given directly into vein into your arm. A nurse will insert an intravenous cannula (commonly called a drip ) will be inserted into your arm. Tysabri 300mg is then added to a bag of fluid called 100ml Normal Saline. A tube is connected to the cannula in your arm and the fluid is given over 1 hour. When the bag is empty, another bag of 100mls Normal Saline is given over 1 hour. This hour is the observation period. It is a medical requirement that you are to be observed and monitored for 1 hour During the infusion and observation period your blood pressure, heart rate and temperature will be checked regularly. Following the Infusion and observation period (2 hours) your cannula will be removed, the nurse will discuss follow-up and appointments with you, you will be given the date for your next Tysabri Infusion and then you are able to be discharged home.

7 Ongoing Tysabri Infusions The next Tysabri Infusion will be given to you in a similar way. The Nurse may spend more time with you discussing your experience of the previous Infusion and any problems you may have experienced. Prior to each infusion it is important that you tell the nurse if you have: - experienced any changes in your MS - had any health problems, including any infections, colds or viruses - commenced, stopped or changed any medications - experienced any significant lifestyle challenges or changes - become pregnant or are considering having children (relevant to male and female patients) - any other concerns or problems. 1. Monitoring and follow-up You will need to visit your Neurologist at the following times: - between the first and third dose - between the fifth and sixth dose - every six months thereafter. You will also require a blood test to test your liver function after your first, second and sixth dose of Tysabri. The MS Nurse will be available at every Infusion session to answer your questions or concerns and is available via: jodi.haartsen@easternhealth.org.au or on OFFICE: MS office on Tuesday, Thursday and Friday MOBILE: at any other time for help when you need it. 2. Planning for pregnancy Tysabri is not recommended in pregnancy or while breastfeeding. If you (male or female) are planning for pregnancy, please consider your timelines carefully before starting Tysabri. If you would like to become pregnant (male or female) and are currently receiving Tysabri, please discuss this with your MS Nurse or MS Neurologist as you must discontinue Tysabri therapy before trying to conceive a child.

Oxford University Hospitals. NHS Trust. Department of Neurology Natalizumab (Tysabri) for Multiple Sclerosis. Information for patients

Oxford University Hospitals. NHS Trust. Department of Neurology Natalizumab (Tysabri) for Multiple Sclerosis. Information for patients Oxford University Hospitals NHS Trust Department of Neurology Natalizumab (Tysabri) for Multiple Sclerosis Information for patients page 2 What is Natalizumab and what is it used for? Natalizumab is an

More information

Disease Modifying Therapies for MS

Disease Modifying Therapies for MS Disease Modifying Therapies for MS The term disease-modifying therapy means a drug that can modify or change the course of a disease. In other words a DMT should be able to reduce the number of attacks

More information

Disease Modifying Therapies for MS

Disease Modifying Therapies for MS Disease Modifying Therapies for MS The term disease-modifying therapy (DMT) means a drug that can modify or change the course of a disease. In other words a DMT should be able to reduce the number of attacks

More information

Multiple sclerosis disease-modifying drugs second line treatments

Multiple sclerosis disease-modifying drugs second line treatments Great Ormond Street Hospital for Children NHS Foundation Trust: Information for Families Multiple sclerosis disease-modifying drugs second line treatments The following information should be read in conjunction

More information

MS Treatments Gilenya

MS Treatments Gilenya 1 MSology Essentials Series Gilenya (fingolimod) Developed by MSology with the invaluable assistance of multiple sclerosis nurse advisors: Trudy Campbell Dalhousie MS Research Unit, Capital Health, Halifax,

More information

IF YOU ARE RECEIVING TREATMENT WITH TYSABRI FOR RELAPSING-REMITTING MS (NATALIZUMAB)

IF YOU ARE RECEIVING TREATMENT WITH TYSABRI FOR RELAPSING-REMITTING MS (NATALIZUMAB) IF YOU ARE RECEIVING (NATALIZUMAB) TREATMENT WITH TYSABRI FOR RELAPSING-REMITTING MS Read the patient information leaflet that accompanies the medicine carefully. 1 This brochure is a supplement to the

More information

MS Treatments Aubagio TM

MS Treatments Aubagio TM 1 MSology Essentials Series Aubagio TM (teriflunomide) Developed by MSology with the invaluable assistance of multiple sclerosis nurse advisors: Bonnie Blain Central Alberta MS Clinic, Red Deer, Alberta

More information

Disease modifying drug therapy

Disease modifying drug therapy Disease modifying drug therapy what you need to know Third Edition Karen Alldus Simon Webster SECTION 2 We hope you find the information in this book helpful. If you would like to speak with someone about

More information

Natalizumab (Tysabri)

Natalizumab (Tysabri) Natalizumab (Tysabri) Spirella Building, Letchworth, SG6 4ET 01462 476700 www.mstrust.org.uk reg charity no. 1088353 Natalizumab (Tysabri) Date of issue: July 2010 Review date: July 2011 Contents Section

More information

New treatments in MS What s here and what s nearly here

New treatments in MS What s here and what s nearly here 5 th MS Research Day, June 14 th 2014 New treatments in MS What s here and what s nearly here David Miller Queen Square MS Centre at UCL and UCLH Course of MS and its treatment Relapsing remitting Disability

More information

Disease modifying drug therapy

Disease modifying drug therapy Disease modifying drug therapy New edition for 2014-15 We hope you find the information in this book helpful. If you would like to speak with someone about any aspect of MS, contact the MS Trust information

More information

Teriflunomide (Aubagio) 14mg once daily tablet

Teriflunomide (Aubagio) 14mg once daily tablet Teriflunomide (Aubagio) 14mg once daily tablet Exceptional healthcare, personally delivered Your Consultant Neurologist has suggested that you may benefit from treatment with Teriflunomide. The decision

More information

Gilenya. Exceptional healthcare, personally delivered

Gilenya. Exceptional healthcare, personally delivered Gilenya Exceptional healthcare, personally delivered Your Consultant Neurologist has suggested that you may benefit from treatment with Gilenya. The decision to start this form of treatment can be difficult.

More information

Human Normal Immunoglobulin Solution for Intravenous Infusion.

Human Normal Immunoglobulin Solution for Intravenous Infusion. CONSUMER MEDICINE INFORMATION (CMI) OCTAGAM Human Normal Immunoglobulin Solution for Intravenous Infusion. OCTAGAM is available in single use bottles of 20 ml, 50 ml, 100 ml and 200 ml. OCTAGAM contains

More information

Progress in MS: Current and Emerging Therapies

Progress in MS: Current and Emerging Therapies Progress in MS: Current and Emerging Therapies Presented by: Dr. Kathryn Giles, MD MSc FRCPC The MS Society gratefully acknowledges the grant received from Biogen Idec Canada, which makes possible the

More information

Temozolomide (oral) with concurrent radiotherapy to the brain

Temozolomide (oral) with concurrent radiotherapy to the brain Temozolomide (oral) with concurrent radiotherapy to the brain Temozolomide (oral) with concurrent radiotherapy to the brain This leaflet is offered as a guide to you and your family. You will find it useful

More information

The MS Disease- Modifying Drugs. Gener al information

The MS Disease- Modifying Drugs. Gener al information The MS Disease- Modifying Drugs Gener al information Current as of October 30, 2009. This online version is updated as breaking news requires. If you have downloaded and printed a copy from the web, please

More information

BREAST CANCER TREATMENT

BREAST CANCER TREATMENT BREAST CANCER TREATMENT Cancer Care Pathways Directorate Tailored Information in Cancer Care (TICC) Sir Anthony Mamo Oncology Centre December 2014 Contents About this booklet 1 Your First Oncology Consultation

More information

Mitoxantrone. For multiple sclerosis. InfoNEURO INFORMATION FOR PATIENTS. Montreal Neurological Hospital

Mitoxantrone. For multiple sclerosis. InfoNEURO INFORMATION FOR PATIENTS. Montreal Neurological Hospital i InfoNEURO Montreal Neurological Hospital INFORMATION FOR PATIENTS Mitoxantrone For multiple sclerosis Centre universitaire de santé McGill McGill University Health Centre Collaborators: D. Lowden Clinical

More information

How long will it take to work? You may begin to feel better within a few days or it may take up to six weeks after your first treatment session.

How long will it take to work? You may begin to feel better within a few days or it may take up to six weeks after your first treatment session. Crohn's and Colitis UK Drug Treatment Information Improving life for people affected by inflammatory bowel diseases Infliximab This information leaflet aims to answer common questions you may have if you

More information

MEDICATION GUIDE STELARA

MEDICATION GUIDE STELARA MEDICATION GUIDE STELARA (stel ar a) (ustekinumab) Injection What is the most important information I should know about STELARA? STELARA is a medicine that affects your immune system. STELARA can increase

More information

VAD Chemotherapy Regimen for Multiple Myeloma Information for Patients

VAD Chemotherapy Regimen for Multiple Myeloma Information for Patients VAD Chemotherapy Regimen for Multiple Myeloma Information for Patients The Regimen contains: V = vincristine (Oncovin ) A = Adriamycin (doxorubicin) D = Decadron (dexamethasone) How Is This Regimen Given?

More information

Intravenous Immunoglobulin in Neurological disorders

Intravenous Immunoglobulin in Neurological disorders Intravenous Immunoglobulin in Neurological disorders Exceptional healthcare, personally delivered What is Intravenous Immunoglobulin (IVIg)? Intravenous immunoglobulin (IVIg) is a blood product that combines

More information

CHOP Chemotherapy Regimen for Lymphoma Information for Patients

CHOP Chemotherapy Regimen for Lymphoma Information for Patients CHOP Chemotherapy Regimen for Lymphoma Information for Patients The Regimen Contains: C: Cytoxan (cyclophosphamide) H: Adriamycin (hydroxy doxorubicin) O: vincristine (Oncovin ) P: Prednisone How Is This

More information

I B2.4. Design of the patient information leaflet for VariQuin

I B2.4. Design of the patient information leaflet for VariQuin (English translation of official Dutch version) I B2.4. Design of the patient information leaflet for VariQuin Information for the Patient: Read this package leaflet carefully when you have some time to

More information

MEDICATION GUIDE POMALYST (POM-uh-list) (pomalidomide) capsules. What is the most important information I should know about POMALYST?

MEDICATION GUIDE POMALYST (POM-uh-list) (pomalidomide) capsules. What is the most important information I should know about POMALYST? MEDICATION GUIDE POMALYST (POM-uh-list) (pomalidomide) capsules What is the most important information I should know about POMALYST? Before you begin taking POMALYST, you must read and agree to all of

More information

CVP Chemotherapy Regimen for Lymphoma Information for Patients

CVP Chemotherapy Regimen for Lymphoma Information for Patients CVP Chemotherapy Regimen for Lymphoma Information for Patients The Regimen Contains: C: Cyclophosphamide (Cytoxan ) V: Vincristine (Oncovin ) P: Prednisone How Is This Regimen Given? CVP is given every

More information

PATIENT MEDICATION INFORMATION

PATIENT MEDICATION INFORMATION READ THIS FOR SAFE AND EFFECTIVE USE OF YOUR MEDICINE PATIENT MEDICATION INFORMATION Pr CYRAMZA ramucirumab Read this carefully before you receive CYRAMZA (pronounced "si ram - ze"). This leaflet is a

More information

FastTest. You ve read the book... ... now test yourself

FastTest. You ve read the book... ... now test yourself FastTest You ve read the book...... now test yourself To ensure you have learned the key points that will improve your patient care, read the authors questions below. The answers will refer you back to

More information

UW MEDICINE PATIENT EDUCATION. Xofigo Therapy. For metastatic prostate cancer. What is Xofigo? How does it work?

UW MEDICINE PATIENT EDUCATION. Xofigo Therapy. For metastatic prostate cancer. What is Xofigo? How does it work? UW MEDICINE PATIENT EDUCATION Xofigo Therapy For metastatic prostate cancer This handout explains how the drug Xofigo is used to treat metastatic prostate cancer. What is Xofigo? Xofigo is a radioactive

More information

QUESTIONS TO ASK MY DOCTOR

QUESTIONS TO ASK MY DOCTOR Be a part of the treatment decision by asking questions QUESTIONS TO ASK MY DOCTOR FOR PATIENTS WITH ADVANCED STOMACH OR GASTROESOPHAGEAL JUNCTION (GEJ) CANCER CYRAMZA (ramucirumab) is used alone or in

More information

Which injectable medication should I take for relapsing-remitting multiple sclerosis?

Which injectable medication should I take for relapsing-remitting multiple sclerosis? Which injectable medication should I take for relapsing-remitting multiple sclerosis? A decision aid to discuss options with your doctor This decision aid is for you if you: Have multiple sclerosis Have

More information

READ THIS FOR SAFE AND EFFECTIVE USE OF YOUR MEDICINE PATIENT MEDICATION INFORMATION. [new-ka la]

READ THIS FOR SAFE AND EFFECTIVE USE OF YOUR MEDICINE PATIENT MEDICATION INFORMATION. [new-ka la] READ THIS FOR SAFE AND EFFECTIVE USE OF YOUR MEDICINE PATIENT MEDICATION INFORMATION Pr NUCALA [new-ka la] mepolizumab lyophilized powder for subcutaneous injection Read this carefully before you start

More information

Relapsing-remitting multiple sclerosis Ambulatory with or without aid

Relapsing-remitting multiple sclerosis Ambulatory with or without aid AVONEX/BETASERON/COPAXONE/EXTAVIA/GILENYA/REBIF/TYSABRI Applicant must be covered on an Alberta Government sponsored drug program. Page 1 of 5 PATIENT INFMATION Surname First Name Middle Initial Sex Date

More information

Liver Disease & Hepatitis Program Providers: Brian McMahon, MD, Steve Livingston, MD, Lisa Townshend, ANP. Primary Care Provider:

Liver Disease & Hepatitis Program Providers: Brian McMahon, MD, Steve Livingston, MD, Lisa Townshend, ANP. Primary Care Provider: Liver Disease & Hepatitis Program Providers: Brian McMahon, MD, Steve Livingston, MD, Lisa Townshend, ANP Primary Care Provider: If you are considering hepatitis C treatment, please read this treatment

More information

Understanding How Existing and Emerging MS Therapies Work

Understanding How Existing and Emerging MS Therapies Work Understanding How Existing and Emerging MS Therapies Work This is a promising and hopeful time in the field of multiple sclerosis (MS). Many new and different therapies are nearing the final stages of

More information

Facts About Chickenpox and Shingles for Adults

Facts About Chickenpox and Shingles for Adults Facts About Chickenpox and Shingles for Adults What is chickenpox? Chickenpox, also known as varicella, is a very contagious disease caused by the varicella-zoster virus. It is spread easily through the

More information

Voting for your top research questions Survey

Voting for your top research questions Survey MS Priority Setting Partnership Voting for your top research questions Survey Prioritising important research questions for multiple sclerosis a partnership between people affected by MS and healthcare

More information

What You Need to Know About LEMTRADA (alemtuzumab) Treatment: A Patient Guide

What You Need to Know About LEMTRADA (alemtuzumab) Treatment: A Patient Guide For Patients What You Need to Know About LEMTRADA (alemtuzumab) Treatment: A Patient Guide Patients: Your doctor or nurse will go over this patient guide with you. It is important to ask any questions

More information

TYSABRI Risk Management Plan. Carmen Bozic, MD Vice President Drug Safety and Risk Management Biogen Idec Inc

TYSABRI Risk Management Plan. Carmen Bozic, MD Vice President Drug Safety and Risk Management Biogen Idec Inc 76 TYSABRI Risk Management Plan Carmen Bozic, MD Vice President Drug Safety and Risk Management Biogen Idec Inc 77 Presentation Outline Overview and Goals of Plan Risk Minimization Plan Risk Assessment

More information

TCH: Docetaxel, Carboplatin and Trastuzumab

TCH: Docetaxel, Carboplatin and Trastuzumab PATIENT EDUCATION patienteducation.osumc.edu TCH: Docetaxel, Carboplatin and Trastuzumab What is TCH? It is the short name for the drugs used for this chemotherapy treatment. The three drugs you will receive

More information

National Multiple Sclerosis Society. Disease Modification in Multiple Sclerosis. Current as of January 2, 2013

National Multiple Sclerosis Society. Disease Modification in Multiple Sclerosis. Current as of January 2, 2013 National Multiple Sclerosis Society Disease Modification in Multiple Sclerosis Current as of January 2, 2013 Since 1993, the U.S. Food and Drug Administration (FDA) has approved several medications for

More information

Yoon Nofsinger, M.D. Tampa ENT Associates, 3450 East Fletcher Avenue, Tampa, FL 33613 Phone (813) 972-3353, Fax (813) 978 3667

Yoon Nofsinger, M.D. Tampa ENT Associates, 3450 East Fletcher Avenue, Tampa, FL 33613 Phone (813) 972-3353, Fax (813) 978 3667 Yoon Nofsinger, M.D. Tampa ENT Associates, 3450 East Fletcher Avenue, Tampa, FL 33613 Phone (813) 972-3353, Fax (813) 978 3667 General Information: Allergies and Injection Therapy 1. General: You have

More information

Understanding your Tecfidera treatment

Understanding your Tecfidera treatment Understanding your Tecfidera treatment Information for patients who have been prescribed treatment with Tecfidera. (dimethyl fumarate) Contents About Multiple Sclerosis (MS) What is MS? Symptoms of MS

More information

Understanding your Tecfidera treatment

Understanding your Tecfidera treatment Understanding your Tecfidera treatment Information for patients who have been prescribed treatment with Tecfidera. (dimethyl fumarate) Contents About Multiple Sclerosis (MS) What is MS? Symptoms of MS

More information

Information About Medicines for Multiple Sclerosis

Information About Medicines for Multiple Sclerosis Information About Medicines for Multiple Sclerosis Information About Medicines for Multiple Sclerosis What is multiple sclerosis? 1 Multiple sclerosis (MS) is a lifelong disease that affects your brain

More information

X-Plain Low Testosterone Reference Summary

X-Plain Low Testosterone Reference Summary X-Plain Low Testosterone Reference Summary Introduction Testosterone is the most important male sex hormone. It helps the body produce and maintain adult male features. Low levels of testosterone affect

More information

Treating Chronic Hepatitis C. A Review of the Research for Adults

Treating Chronic Hepatitis C. A Review of the Research for Adults Treating Chronic Hepatitis C A Review of the Research for Adults Is This Information Right for Me? Yes, this information is right for you if: Your doctor* has told you that you have chronic hepatitis C.

More information

Paclitaxel and Carboplatin

Paclitaxel and Carboplatin PATIENT EDUCATION patienteducation.osumc.edu What is Paclitaxel (pak-li-tax-el) and how does it work? Paclitaxel is a chemotherapy drug known as an anti-microtubule inhibitor. Another name for this drug

More information

Information about medicines for multiple sclerosis

Information about medicines for multiple sclerosis Information about medicines for multiple sclerosis Information about medicines for multiple sclerosis What is multiple sclerosis? 1 Multiple sclerosis (MS) is a lifelong disease that affects your brain

More information

2 What you need to know before you have Ampiclox

2 What you need to know before you have Ampiclox Reason for update: GDS 14 & QRD Updates Response to questions for variation update section 4.1 of SPC MHRA Submission Date: 6 November 2014 MHRA Approval Date: Text Date: October 2014 Text Issue and Draft

More information

Package leaflet: Information for the patient. Entyvio 300 mg powder for concentrate for solution for infusion vedolizumab

Package leaflet: Information for the patient. Entyvio 300 mg powder for concentrate for solution for infusion vedolizumab Package leaflet: Information for the patient Entyvio 300 mg powder for concentrate for solution for infusion vedolizumab This medicine is subject to additional monitoring. This will allow quick identification

More information

The MS Disease- Modifying Medications GENERAL INFORMATION

The MS Disease- Modifying Medications GENERAL INFORMATION The MS Disease- Modifying Medications GENERAL INFORMATION Current as of March 2014. This online brochure is updated with breaking news as required. If you have a printed a copy of this publication, please

More information

SECTION 2. Section 2 Multiple Sclerosis (MS) Drug Coverage

SECTION 2. Section 2 Multiple Sclerosis (MS) Drug Coverage SECTION 2 Multiple Sclerosis (MS) Drug Coverage Section 2 Multiple Sclerosis (MS) Drug Coverage ALBERTA HEALTH AND WELLNESS DRUG BENEFIT LIST Selected Drug Products used in the treatment of patients with

More information

University College Hospital. Contrast agent for radiotherapy CT (computed tomography) scans. Radiotherapy Department Patient information series

University College Hospital. Contrast agent for radiotherapy CT (computed tomography) scans. Radiotherapy Department Patient information series University College Hospital Contrast agent for radiotherapy CT (computed tomography) scans Radiotherapy Department Patient information series 11 2 If you need a large print, audio or translated copy of

More information

Patient identifier/label: Page 1 of 6 PATIENT AGREEMENT TO SYSTEMIC THERAPY: CONSENT FORM FEC-T. Patient s first names. Date of birth.

Patient identifier/label: Page 1 of 6 PATIENT AGREEMENT TO SYSTEMIC THERAPY: CONSENT FORM FEC-T. Patient s first names. Date of birth. Patient identifier/label: Page 1 of 6 PATIENT AGREEMENT TO SYSTEMIC THERAPY: CONSENT FORM FEC-T Patient s surname/family name Patient s first names Date of birth Hospital Name: Guy s Hospital St. Thomas

More information

Patient Guide. Important information for patients starting therapy with LEMTRADA (alemtuzumab)

Patient Guide. Important information for patients starting therapy with LEMTRADA (alemtuzumab) Patient Guide Important information for patients starting therapy with LEMTRADA (alemtuzumab) This medicinal product is subject to additional monitoring. This will allow quick identification of new safety

More information

FAQs on Influenza A (H1N1-2009) Vaccine

FAQs on Influenza A (H1N1-2009) Vaccine FAQs on Influenza A (H1N1-2009) Vaccine 1) What is Influenza A (H1N1-2009) (swine flu) 1? Influenza A (H1N1-2009), previously known as "swine flu", is a new strain of influenza virus that spreads from

More information

CNS DEMYLINATING DISORDERS

CNS DEMYLINATING DISORDERS CNS DEMYLINATING DISORDERS Multiple sclerosis A Dutch saint named Lidwina, who died in 1433, may have been one of the first known MS patients. After she fell while ice skating, she developed symptoms such

More information

Your Treatment with Bacillus Calmette- Guérin (BCG)

Your Treatment with Bacillus Calmette- Guérin (BCG) Your Treatment with Bacillus Calmette- Guérin (BCG) Patient Information Introduction Your consultant has prescribed BCG for the treatment of your bladder tumour. This booklet does not replace the discussion

More information

Original Policy Date

Original Policy Date MP 5.01.20 Tysabri (natalizumab) Medical Policy Section Prescription Drug Issue 12:2013 Original Policy Date 12:2013 Last Review Status/Date Local Policy/12:2013 Return to Medical Policy Index Disclaimer

More information

Gemcitabine and Cisplatin

Gemcitabine and Cisplatin PATIENT EDUCATION patienteducation.osumc.edu What is Gemcitabine (jem-site-a been)? Gemcitabine is a chemotherapy medicine known as an anti-metabolite. Another name for this drug is Gemzar. This drug is

More information

INITIATING ORAL AUBAGIO (teriflunomide) THERAPY

INITIATING ORAL AUBAGIO (teriflunomide) THERAPY FOR YOUR PATIENTS WITH RELAPSING FORMS OF MS INITIATING ORAL AUBAGIO (teriflunomide) THERAPY WARNING: HEPATOTOXICITY AND RISK OF TERATOGENICITY Severe liver injury including fatal liver failure has been

More information

Biologic Treatments for Rheumatoid Arthritis

Biologic Treatments for Rheumatoid Arthritis Biologic Treatments Rheumatoid Arthritis (also known as cytokine inhibitors, TNF inhibitors, IL 1 inhibitor, or Biologic Response Modifiers) Description Biologics are new class of drugs that have been

More information

X-Plain Chemotherapy for Breast Cancer - Adriamycin, Cytoxan, and Tamoxifen Reference Summary

X-Plain Chemotherapy for Breast Cancer - Adriamycin, Cytoxan, and Tamoxifen Reference Summary X-Plain Chemotherapy for Breast Cancer - Adriamycin, Cytoxan, and Tamoxifen Reference Summary Introduction Breast cancer is a common condition that affects one out of every 11 women. Your doctor has recommended

More information

Betaferon (interferon beta 1b)

Betaferon (interferon beta 1b) Betaferon (interferon beta 1b) What is Betaferon? Betaferon (interferon beta-1b) is a type of medicine known as an interferon, which is used to treat MS. Interferons are proteins found naturally in the

More information

Multiple Sclerosis: What You Need To Know. For Professionals

Multiple Sclerosis: What You Need To Know. For Professionals Multiple Sclerosis: What You Need To Know For Professionals What will I learn today? The Basics: What is MS? Living with MS: A Family Affair We Can Help: The National MS Society What MS Is: MS is thought

More information

Your NHL Journey. RITUXAN for Follicular Lymphoma and Diffuse Large B-cell Lymphoma (DLBCL) Indications. Important Safety Information

Your NHL Journey. RITUXAN for Follicular Lymphoma and Diffuse Large B-cell Lymphoma (DLBCL) Indications. Important Safety Information * Your NHL Journey RITUXAN for Follicular Lymphoma and Diffuse Large B-cell Lymphoma (DLBCL) * Non-Hodgkin s Lymphoma Indications RITUXAN (rituximab) is indicated for the treatment of: Follicular CD20-positive

More information

Contents Page. 1. What is IV DHE? 3. 2. Medication Licence 3. 3. How can a course of IV DHE help? 4. 4. What are the side effects of IV DHE?

Contents Page. 1. What is IV DHE? 3. 2. Medication Licence 3. 3. How can a course of IV DHE help? 4. 4. What are the side effects of IV DHE? If you would like this document in another language or format, or if you require the services of an interpreter, please contact us on extension 84299 or 83926. Switchboard: 0845 155 5000 020 3456 7890

More information

Health Information Form for Adults

Health Information Form for Adults A. IDENTIFICATION B. EMERGENCY CONTACTS Name (Last) (First) (Middle) Maiden Name Primary Alternate In Case of Emergency, Notify: Primary Contact Name (Last) (First) (Middle) Relationship Home Work Home

More information

Chickenpox in pregnancy: what you need to know

Chickenpox in pregnancy: what you need to know Chickenpox in pregnancy: what you need to know First published December 2003 Revised edition published November 2008 What is chickenpox? Chickenpox is a very infectious illness caused by a virus called

More information

1g cream or ointment contains 1 mg methylprednisolone aceponate.

1g cream or ointment contains 1 mg methylprednisolone aceponate. CONSUMER MEDICINE INFORMATION ADVANTAN 1g cream or ointment contains 1 mg methylprednisolone aceponate. What is in this leaflet Please read this leaflet carefully before you start using ADVANTAN. It will

More information

Disease modifying drug therapy. what you need to know

Disease modifying drug therapy. what you need to know Disease modifying drug therapy what you need to know Contact information Neurologist s name: Neurologist s secretary: Telephone number: MS specialist nurse: Telephone number: Manufacturer helpline number:

More information

Rituximab. Drug information Rituximab. This leaflet provides information on rituximab and will answer any questions you have about the treatment.

Rituximab. Drug information Rituximab. This leaflet provides information on rituximab and will answer any questions you have about the treatment. Drug information Rituximab Rituximab This leaflet provides information on rituximab and will answer any questions you have about the treatment. Arthritis Research UK produce and print our booklets entirely

More information

Answering your questions on Chronic Myeloid Leukaemia (CML)

Answering your questions on Chronic Myeloid Leukaemia (CML) Answering your questions on Chronic Myeloid Leukaemia (CML) Your guide to understanding CML and Glivec (imatinib) treatment The information in this booklet is designed to help you understand chronic myeloid

More information

Stepping toward a different treatment option LEARN WHAT ACTHAR CAN DO FOR YOU

Stepping toward a different treatment option LEARN WHAT ACTHAR CAN DO FOR YOU FOR MS RELAPSES Stepping toward a different treatment option LEARN WHAT ACTHAR CAN DO FOR YOU As a person with multiple sclerosis (MS), you know firsthand the profound impact MS relapses can have on your

More information

TC: Docetaxel and Cyclophosphamide

TC: Docetaxel and Cyclophosphamide PATIENT EDUCATION patienteducation.osumc.edu What is TC? It is the short name for the drugs used for this chemotherapy treatment. The two drugs you will receive during this treatment are Docetaxel (Taxotere

More information

New England Pain Management Consultants At New England Baptist Hospital

New England Pain Management Consultants At New England Baptist Hospital New England Pain Management Consultants At New England Baptist Hospital Pain Management Center Health Assessment Dear New Pain Management Patient, Welcome to the New England Pain Management Consultants

More information

Resources for the Primary Care Provider. Please print these out for reference

Resources for the Primary Care Provider. Please print these out for reference Resources for the Primary Care Provider Please print these out for reference Resources for providers American Academy of Neurology www.aan.com Provides education and resources, such as guidelines for clinical

More information

TC Chemotherapy Regimen (Docetaxel + Cyclophosphamide)

TC Chemotherapy Regimen (Docetaxel + Cyclophosphamide) TC Chemotherapy Regimen (Docetaxel + Cyclophosphamide) TC is a regimen or treatment plan that includes a combination of chemotherapy drugs that your doctor prescribed for the treatment of your cancer.

More information

Positron Emission Tomography - For Patients

Positron Emission Tomography - For Patients Positron Emission Tomography - For Patients A physician s written order is required for any PET-CT tests. How should I prepare for my PET-CT? PET-CT is more complicated than most other tests you may be

More information

MULTIPLE SCLEROSIS. Mary Beth Rensberger, RN, BSN, MPH Author

MULTIPLE SCLEROSIS. Mary Beth Rensberger, RN, BSN, MPH Author MULTIPLE SCLEROSIS Mary Beth Rensberger, RN, BSN, MPH Author All rights reserved. Purchasers of this module are permitted to reproduce the forms contained herein for their individual internal use only.

More information

Trastuzumab (Herceptin ) for patients with metastatic breast cancer

Trastuzumab (Herceptin ) for patients with metastatic breast cancer JULY 2007 Incorporates published evidence to November 2006 INFORMATION ABOUT Trastuzumab (Herceptin ) for patients with metastatic breast cancer This information has been developed to help you understand

More information

Mifamurtide (Mepact ) for Osteosarcoma

Mifamurtide (Mepact ) for Osteosarcoma Mifamurtide (Mepact ) for Osteosarcoma Mifamurtide (Mepact ) for Osteosarcoma This leaflet is offered as a guide to you and your family. Your treatment will be fully explained to you by your doctor or

More information

The MS Disease- Modifying Medications

The MS Disease- Modifying Medications The MS Disease- Modifying Medications National MS Society 1 Current as of November 2014. This online brochure is updated with breaking news as required. If you have a printed a copy of this publication,

More information

Recruiting now. Could you help by joining this study?

Recruiting now. Could you help by joining this study? Non-Small Cell Lung Cancer Recruiting now AstraZeneca is looking for men and women with locally advanced or metastatic non-small cell lung cancer (NSCLC) to join ATLANTIC, a clinical study to help investigate

More information

AC: Doxorubicin and Cyclophosphamide

AC: Doxorubicin and Cyclophosphamide PATIENT EDUCATION patienteducation.osumc.edu What is AC? It is the short name for the drugs used for this chemotherapy treatment. The two drugs you will receive during this treatment are Doxorubicin (Adriamycin

More information

Inflammatory breast cancer

Inflammatory breast cancer april 2007 information about Inflammatory breast cancer What is inflammatory breast cancer? Inflammatory breast cancer is a rare and rapidly growing form of breast cancer. Unlike other breast cancers which

More information

abortion your questions answered

abortion your questions answered abortion your questions answered About Marie Stopes International Marie Stopes International is a specialist reproductive healthcare organisation and a registered charity working in both the UK and overseas.

More information

BE SURE. BE SAFE. VACCINATE.

BE SURE. BE SAFE. VACCINATE. DON T GET OR GIVE THE FLU THIS YEAR THANK YOU Vaccination is the only protection. www.immunisation.ie BE SURE. BE SAFE. VACCINATE. FLU VACCINE 2013-2014 Healthcare workers prevent the spread of flu and

More information

Information for you Treatment of venous thrombosis in pregnancy and after birth. What are the symptoms of a DVT during pregnancy?

Information for you Treatment of venous thrombosis in pregnancy and after birth. What are the symptoms of a DVT during pregnancy? Information for you Treatment of venous thrombosis in pregnancy and after birth Published in September 2011 What is venous thrombosis? Thrombosis is a blood clot in a blood vessel (a vein or an artery).

More information

Health Information Form for Adults

Health Information Form for Adults A. Identification B. Emergency Contacts Name (Last) (First) (Middle) Maiden Name In Case of Emergency, Notify: Primary Contact Name (Last) (First) (Middle) Primary Alternate Relationship Home Work Home

More information

YOU AND YOUR ANAESTHETIC

YOU AND YOUR ANAESTHETIC YOU AND YOUR ANAESTHETIC Information Leaflet Your Health. Our Priority. Page 2 of 8 This leaflet aims to answer some of the questions you may have about your anaesthetic and contains fasting instructions.

More information

The Nuts and Bolts of Multiple Sclerosis. Rebecca Milholland, M.D., Ph.D. Center for Neurosciences

The Nuts and Bolts of Multiple Sclerosis. Rebecca Milholland, M.D., Ph.D. Center for Neurosciences The Nuts and Bolts of Multiple Sclerosis Rebecca Milholland, M.D., Ph.D. Center for Neurosciences Objectives Discuss which patients are at risk for Multiple Sclerosis Discuss the diagnostic criteria for

More information

Patient Sticker Multiple Sclerosis Ambulatory Emergency Care Pathway

Patient Sticker Multiple Sclerosis Ambulatory Emergency Care Pathway Multiple Sclerosis Ambulatory Emergency Care Pathway 1 Consultant: Dr M Oldfield Consultant: Dr D Harris Lead Nurse: Catie Paterson Ambulatory Emergency Care (AEC) Unit Patient From ED (Emergency Department)

More information

Intravenous Methyl Prednisolone in Multiple Sclerosis

Intravenous Methyl Prednisolone in Multiple Sclerosis Intravenous Methyl Prednisolone in Multiple Sclerosis Exceptional healthcare, personally delivered Relapse management in multiple sclerosis Relapses in multiple sclerosis (MS) are common and caused by

More information

All about. (bevacizumab) Information for people being treated with Avastin for advanced ovarian cancer

All about. (bevacizumab) Information for people being treated with Avastin for advanced ovarian cancer All about (bevacizumab) Information for people being treated with Avastin for advanced ovarian cancer AVASTIN AT A GLANCE Avastin also known as bevacizumab is a medicine used to treat a number of different

More information

TdaP-Booster (tee-dee-ay-pee boo-ster)

TdaP-Booster (tee-dee-ay-pee boo-ster) New Zealand Consumer Medicine Information TdaP-Booster (tee-dee-ay-pee boo-ster) Tetanus, diphtheria and pertussis (acellular mono-component) vaccine (adsorbed, reduced antigen content) CONSUMER MEDICINE

More information

Blood Transfusion. There are three types of blood cells: Red blood cells. White blood cells. Platelets.

Blood Transfusion. There are three types of blood cells: Red blood cells. White blood cells. Platelets. Blood Transfusion Introduction Blood transfusions can save lives. Every second, someone in the world needs a blood transfusion. Blood transfusions can replace the blood lost from a serious injury or surgery.

More information